The quality of the research programmes with the outstanding...

The quality of the research programmes with the outstanding people involved is the main reason I have faith in the company.My previous post indicates my disappointment with the CR. It still has to be played out fully. IMO there will be a fairly big under subscription from the current shareholders as it has been indicated...you can have what you want and whats left will be attempted to placed ...the reason for this is I dont think the top 20 is going to fully support it which Steve knows...hence the availability of shares...and as I have previously said it has been offered to shareholders as the institutions did not take it all up...so if it goes to SIs they will only be interested in making a profit...so 10% over a month is 120% over a year.The movement upwards is capped until big pharmas start taking interest. Thats fine if it works out that way but it is high risk and if it goes the other way the investment is lost.I am not being negative...just explaining the big dilution in respect to the downside